References
V.D. Pradhan, S.S. Badakere, L.S. Bichile, A.F. Almeida, Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J. Assoc. Physicians India 52, 533–537 (2004)
R. Wu, R. Li, Propylthiouracil-induced autoimmune syndromes: 11 case report. Rheumatol. Int. 32, 679–681 (2012)
M. Lorber, M.E. Gershwin, Y. Shoenfeld, The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Semin. Arthritis Rheum. 24, 105–113 (1994)
G.V. Prasad, S. Bastacky, J.P. Johnson, Propylthiouracil-induced diffuse proliferative lupus nephritis: review of immunological complications. J. Am. Soc. Nephrol. 8, 1205–1210 (1997)
X. Bosch, A. Guilabert, J. Font, Antineutrophil cytoplasmic antibodies. Lancet 368, 404–418 (2006)
M. Kimura, T. Seki, H. Ozawa et al., The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves’ disease who wished to become pregnant. Endocr. J. 60, 383–388 (2013)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taguchi, T., Nakayama, S., Fujimoto, S. et al. Lupus nephritis with positive myeloperoxidase/proteinase 3-antineutrophil cytoplasmic autoantibody that developed after 17 years of propylthiouracil therapy. Endocrine 46, 357–359 (2014). https://doi.org/10.1007/s12020-013-0101-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0101-1